Keyphrases
2 Receptor
14%
5-choice Serial Reaction Time Task
100%
Acetylcholine
42%
Acetylcholinesterase Inhibitors (AChEI)
14%
Amphetamine
57%
Attention Inhibition
100%
Attentional Behavior
28%
Cholinergic Neurotransmission
14%
Combination Trials
14%
Donepezil
14%
Dopamine
42%
Dopamine D1 Receptor
28%
Dopamine D2 Receptor (DRD2)
14%
Dopamine Release
14%
Dopaminergic Neurotransmission
14%
Dopaminergic Pathway
14%
Eticlopride
42%
Flupenthixol
14%
GBR 12909
28%
Impulsive Behavior
100%
Impulsivity
57%
Long-Evans Rats
100%
Mecamylamine
14%
Minimal Impact
14%
Mixed Effects
14%
Neurotransmission
14%
Nicotine
71%
Nicotinic Acetylcholine Receptor (nAChR)
14%
Nicotinic Receptors
28%
Prefrontal Cortex
14%
Receptor Antagonist
71%
Response Inhibition
100%
SCH23390
42%
Synaptic
14%
Task Performance
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylcholine
75%
Amphetamine
100%
Cholinergic Receptor Stimulating Agent
100%
Cholinesterase Inhibitor
25%
Donepezil
25%
Dopamine 1 Receptor
25%
Dopamine 1 Receptor Blocking Agent
25%
Dopamine 2 Receptor Blocking Agent
25%
Dopamine Receptor Stimulating Agent
100%
Eticlopride
75%
Flupentixol
25%
Long Evans Rat
100%
Mecamylamine
25%
Nicotinic Acetylcholine Receptor Agonist
25%
Receptor Antagonist
75%
Vanoxerine
25%
Neuroscience
Acetylcholine
42%
Acetylcholinesterase Inhibitor
14%
Amphetamine
57%
Behavior (Neuroscience)
100%
Cholinergic
100%
Donepezil
14%
Dopamine Receptor D1
28%
Dopamine Receptor D2
14%
Dopamine Release
14%
Dopaminergic
100%
Eticlopride
42%
Flupentixol
14%
Impulsivity
57%
Mecamylamine
14%
Nicotinic Acetylcholine Receptor
14%
Parasympathomimetic Drug
14%
Prefrontal Cortex
14%
Receptor Antagonist
71%
SCH 23390
42%
Synaptic Transmission
28%